Alder BioPharmaceuticals, Inc.

📍 Bothell, United States🗓 Founded 2004👥 138 employees💰 Last funded Mar 2013
Biotechnology🌐 alderbio.com
Website LinkedIn
Alder is a biopharmaceutical company committed to transforming migraine treatment through the discovery, development and commercialization of novel therapeutic antibodies. The company’s mission is to forever change migraine treatment and give people with migraine their lives back. Alder knows the physical and emotional toll migraine can take not just on the individual but also those who care for them. In fact, some of our employees suffer from migraine themselves. To Alder, people with migraine are not “nameless” subjects or data points, but friends, family, and others whose stories motivate Alder to do its best work. The team’s insight into the needs of migraine patients has enabled us to leverage our monoclonal antibody expertise to design best-in-class therapies.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2004
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Alder BioPharmaceuticals, Inc.?
Alder BioPharmaceuticals, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did Alder BioPharmaceuticals, Inc. last raise funding?
The most recent investment in Alder BioPharmaceuticals, Inc. recorded on gritt.io was in March 2013.
When was Alder BioPharmaceuticals, Inc. founded?
Alder BioPharmaceuticals, Inc. was founded in 2004.
What industry is Alder BioPharmaceuticals, Inc. in?
Alder BioPharmaceuticals, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Alder BioPharmaceuticals, Inc. based?
Alder BioPharmaceuticals, Inc. is headquartered in Bothell, United States.